Stock Analysis on Net
Stock Analysis on Net

UnitedHealth Group Inc. (NYSE:UNH)

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity 
Quarterly Data

UnitedHealth Group Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)

Microsoft Excel
Jun 30, 2026 Mar 31, 2026 Dec 31, 2025 Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Medical costs payable 12.57 12.69 12.71 12.74 12.45 11.99 11.47 11.34 11.38 11.97 11.84 11.63 11.40 11.21 11.83 11.96 12.59 12.96 11.54 12.17 11.95 12.10
Accounts payable and accrued liabilities 12.83 12.36 12.28 11.43 11.13 10.84 11.51 11.05 10.80 10.82 11.68 11.05 10.54 10.52 11.28 11.20 10.92 11.33 11.61 11.40 10.94 11.21
Short-term borrowings and current maturities of long-term debt 1.24 2.07 1.96 2.45 1.85 3.22 1.52 1.31 3.98 3.44 1.56 1.88 2.26 3.50 1.27 1.33 2.43 3.03 1.71 1.70 1.84 4.31
Unearned revenues 0.96 1.09 1.10 1.07 0.98 1.06 1.11 1.11 0.90 1.13 1.23 5.43 5.30 5.11 1.25 5.29 0.96 1.21 1.21 1.20 1.12 1.27
Other current liabilities 8.50 8.30 9.06 8.95 9.49 9.52 9.17 9.12 9.54 9.38 9.89 10.50 10.83 10.72 10.70 11.75 11.63 11.33 10.83 10.88 10.55 10.41
Current liabilities 36.10% 36.50% 37.11% 36.64% 35.90% 36.63% 34.79% 33.93% 36.59% 36.74% 36.19% 40.48% 40.33% 41.06% 36.32% 41.53% 38.54% 39.85% 36.89% 37.35% 36.41% 39.30%
Long-term debt, less current maturities 22.44 22.85 23.36 22.96 23.82 23.01 24.26 24.76 22.28 22.47 21.29 20.59 21.15 21.38 22.19 18.69 19.90 18.44 19.97 20.35 21.09 18.24
Deferred income taxes 0.88 0.92 0.78 1.00 1.23 1.26 1.21 1.34 1.27 1.47 1.10 0.78 0.89 1.00 1.13 0.68 1.12 1.34 1.54 1.71 1.73 1.76
Other liabilities 6.37 6.04 5.89 5.83 5.09 5.15 5.34 5.07 5.17 5.22 5.28 4.83 4.73 4.61 5.23 4.98 5.20 5.28 5.55 5.56 5.91 6.30
Noncurrent liabilities 29.69% 29.81% 30.04% 29.79% 30.14% 29.42% 30.82% 31.17% 28.72% 29.15% 27.67% 26.20% 26.78% 26.99% 28.54% 24.36% 26.22% 25.05% 27.07% 27.62% 28.73% 26.29%
Total liabilities 65.79% 66.31% 67.15% 66.44% 66.04% 66.05% 65.61% 65.10% 65.31% 65.90% 63.86% 66.68% 67.11% 68.05% 64.86% 65.89% 64.75% 64.90% 63.96% 64.97% 65.13% 65.60%
Redeemable noncontrolling interests 0.46 0.46 0.52 1.35 1.40 1.41 1.45 1.53 1.59 1.60 1.64 1.57 1.71 1.69 1.99 2.00 2.14 0.69 0.68 0.64 0.62 0.62
Preferred stock, $0.001 par value; no shares issued or outstanding 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Common stock, $0.01 par value 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional paid-in capital 0.00 0.18 0.18 0.12 0.00 0.00 0.00 0.15 0.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Retained earnings 32.60 31.95 30.88 30.96 31.52 31.61 32.20 32.25 32.30 31.71 34.99 33.03 32.12 31.32 35.06 34.44 34.99 35.61 36.35 35.26 34.76 34.71
Accumulated other comprehensive loss -0.81 -0.82 -0.67 -0.70 -0.82 -0.94 -1.14 -0.82 -1.20 -1.21 -2.57 -3.08 -2.73 -2.66 -3.42 -3.74 -3.36 -2.72 -2.54 -2.28 -1.94 -2.35
Shareholders’ equity attributable to UnitedHealth Group 31.79% 31.31% 30.40% 30.38% 30.70% 30.68% 31.06% 31.58% 31.24% 30.50% 32.43% 29.96% 29.39% 28.66% 31.65% 30.71% 31.64% 32.89% 33.82% 32.99% 32.82% 32.37%
Nonredeemable noncontrolling interests 1.96 1.92 1.93 1.83 1.86 1.86 1.88 1.79 1.86 2.00 2.07 1.80 1.79 1.59 1.50 1.41 1.47 1.52 1.55 1.40 1.43 1.42
Total equity 33.74% 33.23% 32.33% 32.22% 32.56% 32.54% 32.95% 33.37% 33.10% 32.50% 34.50% 31.75% 31.18% 30.25% 33.15% 32.12% 33.11% 34.41% 35.36% 34.39% 34.25% 33.78%
Total liabilities, redeemable noncontrolling interests and equity 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%

Based on: 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).

The capital structure remains relatively stable, with total liabilities consistently comprising between 63.86% and 68.05% of the total balance sheet. Total equity maintains a corresponding range of 30.25% to 35.36%, indicating a consistent approach to leveraging and capitalization throughout the observed period.

Current Liability Dynamics and Seasonality
Current liabilities fluctuate between 33.93% and 41.06% of total funding. A distinct seasonal pattern is observed in short-term borrowings and current maturities of long-term debt, which consistently spike during the first quarter of each year—often exceeding 3%—before declining in the following quarters. Medical costs payable and accounts payable remain stable core components, though both show a gradual upward trend toward the end of the period, reaching 12.57% and 12.83% respectively by June 2026.
Long-Term Leverage Trends
A strategic shift toward long-term debt is evident. Long-term debt, less current maturities, increased from approximately 18.24% in early 2021 to a range of 22% to 24% between 2024 and 2026. This expansion in long-term borrowing is the primary driver for the overall increase in noncurrent liabilities, which rose from roughly 26% to nearly 30% of the total balance sheet composition.
Equity Composition and Retained Earnings
Total equity experienced a decline from a peak of 35.36% in December 2021 to a low of 30.25% in March 2023, followed by a gradual recovery to 33.74% by June 2026. Retained earnings, the primary component of equity, show a general downward trend from the 34-36% range in 2021 to 31-32% in the later periods. Simultaneously, accumulated other comprehensive losses have narrowed significantly, improving from a low of -3.74% in September 2022 to -0.81% by June 2026.
Operational Liability Fluctuations
Unearned revenues remained low for most of the period but experienced an anomalous increase between September 2022 and June 2023, peaking at 5.43% before returning to baseline levels near 1%. Other current liabilities exhibit a steady contraction, decreasing from a range of 10-11% in 2021 to 8.50% by mid-2026.

AI Ask an analyst for more